Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4366 AL 4380

Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome

Caraci F, Iulita MF, Pentz R, Flores Aguilar L, Orciani C, Barone C, Romano C, Drago F, Cuello AC.

Eur J Pharmacol. 2017 Dec 15;817:7-19. doi: 10.1016/j.ejphar.2017.10.004. Epub 2017 Oct 5.

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

Ritchie CW, Russ TC, Banerjee S, Barber B, Boaden A, Fox NC, Holmes C, Isaacs JD, Leroi I, Lovestone S, Norton M, O'Brien J, Pearson J, Perry R, Pickett J, Waldman AD, Wong WL, Rossor MN, Burns A.

Alzheimers Res Ther. 2017 Oct 26;9(1):85. doi: 10.1186/s13195-017-0312-4.

Recent Progress in the Pharmacotherapy of Alzheimer's Disease

Khoury R, Patel K, Gold J, Hinds S, Grossberg GT.

Drugs Aging. 2017 Nov;34(11):811-820. doi: 10.1007/s40266-017-0499-x.

18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

Martínez G, Vernooij RW, Fuentes Padilla P, Zamora J, Flicker L, Bonfill Cosp X.

Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.

Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention

Bachurin SO, Gavrilova SI, Samsonova A, Barreto GE, Aliev G.

Pharmacol Res. 2018 Mar;129:216-226. doi: 10.1016/j.phrs.2017.11.021. Epub 2017 Nov 21.

The Role of Chromatography in Alzheimer's Disease Drug Discovery

Fiori J, De Simone A, Naldi M, Andrisano V.

Adv Chromatogr. 2017;53:75-107.

The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP

Gozes I.

Biol Chem. 2016 Mar;397(3):177-84. doi: 10.1515/hsz-2015-0152.

Yeast as a Model for Alzheimer's Disease: Latest Studies and Advanced Strategies

Verduyckt M, Vignaud H, Bynens T, Van den Brande J, Franssens V, Cullin C, Winderickx J.

Methods Mol Biol. 2016;1303:197-215. doi: 10.1007/978-1-4939-2627-5_11.

Levetiracetam might act as an efficacious drug to attenuate cognitive deficits of Alzheimer's disease

Xiao R.

Curr Top Med Chem. 2016;16(5):565-73. doi: 10.2174/1568026615666150813144603.

Anti-Alzheimer Therapeutic Drugs Targeting γ-Secretase

Tan Y, Zhang Q, Wong SG, Hua Q.

Curr Top Med Chem. 2016;16(5):549-57. doi: 10.2174/1568026615666150813144151.

Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer's Disease Therapy

Li L, Zhang L, Yang CC.

Curr Top Med Chem. 2016;16(5):537-48. doi: 10.2174/1568026615666150813144003.

Ginseng for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Wang Y, Yang G, Gong J, Lu F, Diao Q, Sun J, Zhang K, Tian J, Liu J.

Curr Top Med Chem. 2016;16(5):529-36. doi: 10.2174/1568026615666150813143753.

Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Yang G, Wang Y, Sun J, Zhang K, Liu J.

Curr Top Med Chem. 2016;16(5):520-8. doi: 10.2174/1568026615666150813143520.

Targeting Insulin Signaling for the Treatment of Alzheimer's Disease

Chen Y, Zhang J, Zhang B, Gong CX.

Curr Top Med Chem. 2016;16(5):485-92. doi: 10.2174/1568026615666150813142423.

Editorial: Alzheimer's Disease - Mechanisms, Drug Targets and Alternative Treatments

Hua Q, He R.

Curr Top Med Chem. 2016;16(5):470-1. doi: 10.2174/156802661605151022150458.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias